In focus · trending topic

breakthrough

1 stories · following the connections

U.S. Food and Drug Administration Grants Breakthrough Therapy Designation for Adaptimmune’s Affinity Enhanced T-cell Therapy Targeting NY-ESO in Synovial Sarcoma

By Nasdaq OMXFeb 9, 2016, 4:59 PM UTC